Correlation Between Ikena Oncology and Coherus BioSciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ikena Oncology and Coherus BioSciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ikena Oncology and Coherus BioSciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ikena Oncology and Coherus BioSciences, you can compare the effects of market volatilities on Ikena Oncology and Coherus BioSciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ikena Oncology with a short position of Coherus BioSciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ikena Oncology and Coherus BioSciences.

Diversification Opportunities for Ikena Oncology and Coherus BioSciences

0.02
  Correlation Coefficient

Significant diversification

The 3 months correlation between Ikena and Coherus is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Ikena Oncology and Coherus BioSciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coherus BioSciences and Ikena Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ikena Oncology are associated (or correlated) with Coherus BioSciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coherus BioSciences has no effect on the direction of Ikena Oncology i.e., Ikena Oncology and Coherus BioSciences go up and down completely randomly.

Pair Corralation between Ikena Oncology and Coherus BioSciences

Given the investment horizon of 90 days Ikena Oncology is expected to under-perform the Coherus BioSciences. But the stock apears to be less risky and, when comparing its historical volatility, Ikena Oncology is 6.33 times less risky than Coherus BioSciences. The stock trades about -0.01 of its potential returns per unit of risk. The Coherus BioSciences is currently generating about 0.32 of returns per unit of risk over similar time horizon. If you would invest  72.00  in Coherus BioSciences on August 28, 2024 and sell it today you would earn a total of  49.00  from holding Coherus BioSciences or generate 68.06% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Ikena Oncology  vs.  Coherus BioSciences

 Performance 
       Timeline  
Ikena Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ikena Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Ikena Oncology is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.
Coherus BioSciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Coherus BioSciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Coherus BioSciences is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Ikena Oncology and Coherus BioSciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ikena Oncology and Coherus BioSciences

The main advantage of trading using opposite Ikena Oncology and Coherus BioSciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ikena Oncology position performs unexpectedly, Coherus BioSciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coherus BioSciences will offset losses from the drop in Coherus BioSciences' long position.
The idea behind Ikena Oncology and Coherus BioSciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio